Search
Now showing items 1-10 of 11
Leukocyte transfusion for treatment of a chronic myeloid leukemia relapse following allogeneic bone marrow transplantation
Beitrag zu einer Konferenz
(Universität Ulm, 1994)
ROFERON (RIFN-ALPHA(2A)) IS MORE IMMUNOGENIC THAN INTRON-A (RIFN-ALPHA(2B)) IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA
Beitrag zu einer Konferenz
(Universität Ulm, 1994)
MEASUREMENT OF RECIPIENT-SPECIFIC ALLOREACTIVITY - IS GVHD PREDICTABLE
Beitrag zu einer Konferenz
(Universität Ulm, 1993)
AGGRESSIVE CHEMOTHERAPY COMBINED WITH G-CSF AND MAINTENANCE THERAPY WITH INTERLEUKIN-2 FOR PATIENTS WITH ADVANCED MYELODYSPLASTIC SYNDROME, SUBACUTE OR SECONDARY ACUTE MYELOID-LEUKEMIA - INITIAL RESULTS
Beitrag zu einer Konferenz
(Universität Ulm, 1993)
When should the clinician suspect a drug-induced blood dyscrasia, and how should he proceed?
Beitrag zu einer Konferenz
(Universität Ulm, 1996)
New diagnostic imaging procedures in Hodgkin's disease
Beitrag zu einer Konferenz
(Universität Ulm, 1996)
T-helper cells: Their role in the pathogenesis of graft-versus-host disease and graft-versus-leukemia effect
Beitrag zu einer Konferenz
(Universität Ulm, 1996)
GONADAL-FUNCTION AFTER BONE-MARROW TRANSPLANTATION IN ADULT MALE AND FEMALE-PATIENTS
Beitrag zu einer Konferenz
(Universität Ulm, 1991)